| HOME >> BIOLOGY >> TECHNOLOGY |
To Present at Noble Financial 'Double-O-Seven' Small Cap Conference/Microcap Symposium on August 21 and Roth Capital's 2007 New York
Conference on September 5
NEWARK, Del., Aug. 15 /PRNewswire-FirstCall/ -- Strategic Diagnostics Inc. (Nasdaq: SDIX) -- a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, environmental and life science applications, announced today that its President and Chief Executive Officer, Matthew Knight, will present at two investor conferences during the next three weeks.
Mr. Knight will present at Noble Research's "Two-Double-O-Seven" Small Cap Conference/Microcap Symposium at the Charleston Place Hotel in the heart of Charleston South Carolina's historic district. The Company will present at 8:30 a.m. on August 21 in the Goldfinger Room with a live webcast available at the Conference's website, http://www.two-007.net, for approximately 30 days following the conclusion of the presentation. The Company will have a breakout session immediately following the formal presentation in the Diamonds are Forever room. Company management will be available for one-on-one meetings throughout the day, which may be arranged by emailing Noble Research at info@two-007.net.
On September 5, Mr. Knight will present at Roth Capital Partner's Roth
2007 New York Conference at the Westin Hotel in Manhattan. Mr. Knight's
presentation is scheduled for 4:30 p.m. in the Majestic II (Track 1) room.
A webcast of the presentation may be accessed at
http://www.wsw.com/webcast/roth13/sdix/ for approxima
'/>"/>
SOURCE Strategic Diagnostics Inc.![]() Copyright©2007 PR Newswire. |